Regulatory Updates
HSA CEO's messages on facilitating development and access to COVID-19 related therapeutic products and medical devices
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
21 January 2021
Read more about what HSA is doing in the area of COVID-19 related therapeutic products and medical devices.
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
HSA’s efforts in accelerating development and access to essential COVID-19 therapeutics and medical devices
HSA CEO Message Jan 2021 [PDF, 590 KB]
HSA facilitates the development and access of therapeutic products for COVID-19 patients
HSA CEO Message Jun 2020 [PDF, 614 KB]
HSA facilitates the access of respiratory devices for COVID-19 patients, implements 'virtual desk-top audit process' to inspect new facilities manufacturing surgical masks in Singapore
HSA CEO Message Apr 2020 [PDF, 692 KB]